drugset

drugset / Trial / NCT06998732

BCD to Measure the ED95 of Remimazolam-Assisted Sedation in Arteriovenous Fistula Creation Surgery

NCT06998732 ↗

Phase 4 Not yet recruiting 40 enrolled Gang Chen

NaSingle-groupOpen-labelHealth-services research

Summary

This study intends to measure the ED95 of remimazolam-assisted sedation in arteriovenous fistula creation by BCD.

Timeline

Start: 2025-06-01
Primary completion: 2025-09-30
Completion: 2025-10-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Remimazolam	Small molecule	—	—

Indications